12,051 Septerna, Inc. $SEPN Shares Sold by State of Wyoming

State of Wyoming trimmed its holdings in shares of Septerna, Inc. (NASDAQ:SEPN) by 73.6% in the third quarter, Holdings Channel reports. The firm owned 4,328 shares of the company’s stock after selling 12,051 shares during the period. State of Wyoming’s holdings in Septerna were worth $169,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its position in Septerna by 24.8% in the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 16,600 shares of the company’s stock valued at $650,000 after buying an additional 3,300 shares during the last quarter. China Universal Asset Management Co. Ltd. increased its position in shares of Septerna by 12.5% during the third quarter. China Universal Asset Management Co. Ltd. now owns 12,117 shares of the company’s stock valued at $474,000 after acquiring an additional 1,343 shares during the last quarter. Sterling Capital Management LLC increased its position in shares of Septerna by 215.0% during the third quarter. Sterling Capital Management LLC now owns 630 shares of the company’s stock valued at $25,000 after acquiring an additional 430 shares during the last quarter. First Light Asset Management LLC raised its stake in shares of Septerna by 31.4% in the 2nd quarter. First Light Asset Management LLC now owns 963,260 shares of the company’s stock valued at $32,260,000 after acquiring an additional 230,400 shares during the period. Finally, Engineers Gate Manager LP raised its stake in shares of Septerna by 5.0% in the 2nd quarter. Engineers Gate Manager LP now owns 17,350 shares of the company’s stock valued at $581,000 after acquiring an additional 822 shares during the period.

Septerna Price Performance

Shares of Septerna stock opened at $48.85 on Monday. The business has a 50-day moving average of $39.52 and a 200 day moving average of $32.59. Septerna, Inc. has a 12 month low of $17.55 and a 12 month high of $51.10. The stock has a market capitalization of $2.28 billion, a price-to-earnings ratio of -90.46 and a beta of 2.20.

Septerna (NASDAQ:SEPN) last issued its quarterly earnings results on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.14. The company had revenue of $26.75 million for the quarter, compared to analyst estimates of $19.22 million. Septerna had a negative net margin of 24.51% and a negative return on equity of 9.57%. Equities research analysts anticipate that Septerna, Inc. will post -1.41 earnings per share for the current year.

Insider Activity

In other news, COO Elizabeth Bhatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $37.41, for a total value of $149,640.00. Following the completion of the transaction, the chief operating officer owned 174,209 shares of the company’s stock, valued at approximately $6,517,158.69. This trade represents a 2.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Daniel Long sold 3,333 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $37.83, for a total transaction of $126,087.39. Following the completion of the transaction, the senior vice president directly owned 96,412 shares of the company’s stock, valued at approximately $3,647,265.96. The trade was a 3.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,333 shares of company stock worth $1,375,727 in the last three months. Corporate insiders own 5.80% of the company’s stock.

Analysts Set New Price Targets

SEPN has been the topic of several recent analyst reports. Wells Fargo & Company upped their price objective on shares of Septerna from $50.00 to $61.00 and gave the stock an “overweight” rating in a report on Wednesday, November 4th. Guggenheim lifted their target price on shares of Septerna from $51.00 to $65.00 and gave the company a “buy” rating in a report on Friday. JPMorgan Chase & Co. boosted their target price on Septerna from $38.00 to $48.00 and gave the company an “overweight” rating in a research report on Wednesday, August 19th. Raymond James Financial restated a “strong-buy” rating and set a $49.00 price target on shares of Septerna in a research note on Tuesday, August 11th. Finally, Stifel Nicolaus set a $49.00 price target on Septerna in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $55.22.

About Septerna

Septerna, Inc is a clinical-stage biotechnology company focused on discovering and developing oral small-molecule medicines that target G protein-coupled receptors (GPCRs). GPCRs are a large class of cell-surface proteins involved in a wide range of biological processes and represent an important source of potential drug targets.

The company’s research is powered by its Native State platform, which is designed to study GPCRs in their natural biological configuration and support the discovery of selective small-molecule compounds.